Literature DB >> 15630047

Angiotensin II and the endothelium: diverse signals and effects.

Tetsu Watanabe1, Thomas A Barker, Bradford C Berk.   

Abstract

The initial view of the renin-angiotensin system focused on the role of angiotensin II as a hormone involved in blood pressure control, based on its role in renal salt and water regulation, as well as central nervous system (thirst) and vascular smooth muscle tone. Subsequent data showed a role for angiotensin II in long-term effects on cardiovascular structure, including cardiac hypertrophy and vascular remodeling. Importantly, recent human studies with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers have demonstrated exciting clinical benefits including decreases in incidence of stroke, diabetes, and end-stage renal disease that suggest important new mechanisms of action. In this review, we focus on new roles for the renin-angiotensin system in the endothelium based on the concepts of diverse signals and effects mediated by multiple angiotensin I- and angiotensin II-derived peptides, multiple angiotensin metabolizing enzymes, multiple receptors, and vascular bed-specific intracellular signals.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15630047     DOI: 10.1161/01.HYP.0000153321.13792.b9

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  62 in total

Review 1.  Endothelial dysfunction and coronary artery disease: assessment, prognosis, and treatment.

Authors:  Yasushi Matsuzawa; Amir Lerman
Journal:  Coron Artery Dis       Date:  2014-12       Impact factor: 1.439

Review 2.  Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases.

Authors:  Thomas A Wynn
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

3.  Insulin treatment attenuates renal ADAM17 and ACE2 shedding in diabetic Akita mice.

Authors:  Esam S B Salem; Nadja Grobe; Khalid M Elased
Journal:  Am J Physiol Renal Physiol       Date:  2014-01-22

4.  Valsartan regulates myocardial autophagy and mitochondrial turnover in experimental hypertension.

Authors:  Xin Zhang; Zi-Lun Li; John A Crane; Kyra L Jordan; Aditya S Pawar; Stephen C Textor; Amir Lerman; Lilach O Lerman
Journal:  Hypertension       Date:  2014-04-21       Impact factor: 10.190

Review 5.  Role of the endothelial-to-mesenchymal transition in renal fibrosis of chronic kidney disease.

Authors:  Jianhua He; Yong Xu; Daisuke Koya; Keizo Kanasaki
Journal:  Clin Exp Nephrol       Date:  2013-02-21       Impact factor: 2.801

6.  Estrogen Receptor-β Mediates Estradiol-Induced Pregnancy-Specific Uterine Artery Endothelial Cell Angiotensin Type-2 Receptor Expression.

Authors:  Jay S Mishra; Gigi M Te Riele; Qian-Rong Qi; Thomas J Lechuga; Kathirvel Gopalakrishnan; Dong-Bao Chen; Sathish Kumar
Journal:  Hypertension       Date:  2019-08-05       Impact factor: 10.190

7.  Lymphangiogenic therapy prevents cardiac dysfunction by ameliorating inflammation and hypertension.

Authors:  LouJin Song; Xian Chen; Terri A Swanson; Brianna LaViolette; Jincheng Pang; Teresa Cunio; Michael W Nagle; Shoh Asano; Katherine Hales; Arun Shipstone; Hanna Sobon; Sabra D Al-Harthy; Youngwook Ahn; Steven Kreuser; Andrew Robertson; Casey Ritenour; Frank Voigt; Magalie Boucher; Furong Sun; William C Sessa; Rachel J Roth Flach
Journal:  Elife       Date:  2020-11-17       Impact factor: 8.140

8.  GIT1 mediates HDAC5 activation by angiotensin II in vascular smooth muscle cells.

Authors:  Jinjiang Pang; Chen Yan; Kanchana Natarajan; Megan E Cavet; Michael P Massett; Guoyong Yin; Bradford C Berk
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-02-21       Impact factor: 8.311

Review 9.  Cellular and molecular mechanisms of fibrosis.

Authors:  T A Wynn
Journal:  J Pathol       Date:  2008-01       Impact factor: 7.996

Review 10.  The renin-angiotensin system modulates inflammatory processes in atherosclerosis: evidence from basic research and clinical studies.

Authors:  Fabrizio Montecucco; Aldo Pende; François Mach
Journal:  Mediators Inflamm       Date:  2009-04-14       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.